Link to article on investing.com: https://www.investing.com/analysis/why-investors-should-track-the-prescription-drug-user-fee-act-200583708
Summary:
DUFA dates and content are essential for portfolio managers of healthcare stocks. A single positive or negative announcement from the US Food and Drug Administration (FDA) can send shares of a biotech firm soaring or turn a hot name quickly into a bear market. Among the dozens of corporate event data points provided to our customers, Wall Street Horizon gathers PDUFA dates and content so our clients stay in the know.
Recent Content
-
CEO Uncertainty Spikes After Improving Last Quarter
-
Earnings Season Heats Up, Spotting Two Unusual Reporting Dates in the Consumer Space
-
Data Minds - Triple Threat: Leveraging Data to Manage AI, ESG, and ETF Risks | April 11, 2024 [Recording Available]
-
Seeking Alpha: Q1 2024 Earnings Preview: Will Reports Be Good Enough To Turn Markets Positive
-
Q1 2024 Earnings Preview: Will Reports be Good Enough to Turn Markets Positive?
-
[Podcast] Interactive Brokers: The Ins and Outs of Earnings Announcements
-
Pensions & Investments: U.S. companies increase buyback announcements
-
Shareholder Meetings in Focus as Earnings Season Begins
-
Investing.com: Volatility Ahead: How Shareholder Meetings Could Shake Up Your Portfolio
-
Q2 2024 Investor Conference & Events Highlights